Oncothyreon acquires Alpine Biosciences to enable targeted delivery of multiple thera

[News]

Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.

More... (http://www.news-medical.net/news/20140812/Oncothyreon-acquires-Alpine-Biosciences-to-enable-targeted-delivery-of-multiple-therapeutic-agents.aspx)